VivePeptides logo

Research Collection

Peptides for Arthritis

Peptides investigated in preclinical models of inflammatory joint disease, synovial biology, and cartilage-preservation pathways.

Peptides for Arthritis are research compounds studied for their interactions with synovial inflammation and cytokine signaling pathways implicated in arthritic joint disease. This category spans anti-inflammatory pentadecapeptides, thymosin beta-4 derivatives, melanocortin-pathway tripeptides, and erythropoietin-derived innate repair receptor agonists. All compounds are supplied strictly for in vitro and in vivo laboratory research, not for human or animal use.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

BPC-157 research peptide vial

BPC-157

$75.00View
TB-500 research peptide vial

TB-500

$89.00View
KPV research peptide vial

KPV

$60.00View
ARA-290 research peptide vial

ARA-290

$75.00View

Research Overview

Arthritis Peptide Research: Inflammation, Cytokines, and Cartilage Preservation

Peptides for Arthritis is a research category built around synovial inflammation, cytokine signaling, and cartilage-preservation models rather than structural connective tissue regeneration. It is an active area of preclinical investigation because arthritic joint disease involves overlapping inflammatory cascades, including NF-kB activation, pro-inflammatory cytokine release, and chondrocyte stress responses, that researchers can isolate using distinct peptide tool compounds.

Four mechanism classes are represented here: BPC-157, a cytoprotective pentadecapeptide studied for anti-inflammatory and angiogenic signaling; TB-500, an actin-regulating thymosin beta-4 derivative studied for cell migration in inflamed tissue; KPV, a melanocortin-derived tripeptide studied for NF-kB pathway modulation; and ARA-290, an erythropoietin-derived peptide studied for innate repair receptor signaling and cytoprotection. VivePeptides sources each compound with third-party purity documentation and a certificate of analysis, positioning the catalog for researchers who require verifiable reagent quality in cytokine and inflammation studies.

Four Distinct Mechanism Classes

This collection spans a cytoprotective pentadecapeptide, a thymosin beta-4 derivative, a melanocortin-pathway tripeptide, and an erythropoietin-derived peptide. Each targets a different node in the inflammatory cascade underlying arthritis models.

Purity and Documentation Standards

Each compound ships with third-party purity testing and a certificate of analysis. Researchers can verify identity before designing cytokine or inflammation assays.

Selecting by Cytokine Pathway

Researchers typically choose among these compounds based on the inflammatory pathway under investigation, such as NF-kB signaling, actin-mediated cell migration, or innate repair receptor activity. Model design should match the compound to the specific pathway being studied.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
BPC-157Cytoprotective pentadecapeptideSynovial inflammation, angiogenesis signalingStable in gastric fluid models
TB-500Thymosin beta-4 derivative (actin-binding)Cell migration in inflamed tissueBroad systemic distribution in vivo
KPVMelanocortin-derived tripeptideNF-kB cytokine pathway modulationSmallest molecular weight in class
ARA-290Erythropoietin-derived innate repair receptor agonistCytoprotective signaling without hematopoiesisNon-hematopoietic EPO structural analog

Mechanism & Research Context

Mechanism Classes and Research Context in Joint Inflammation Models

What distinguishes this collection is the mechanistic diversity researchers can apply to a single disease process, arthritic inflammation. BPC-157 has been examined in models of gastric and soft-tissue injury for its influence on nitric oxide signaling and angiogenesis, properties researchers extend to synovial inflammation research.

TB-500 has been investigated for actin-binding activity that supports cell migration, a process relevant to inflamed synovium and periarticular tissue turnover. KPV, derived from the C-terminal tripeptide sequence of alpha-melanocyte-stimulating hormone, has been studied for suppressing NF-kB-mediated cytokine transcription in inflammatory cell models.

ARA-290 has been examined for activity at the innate repair receptor, a tissue-protective pathway distinct from the classical erythropoietin receptor, without hematopoietic effects. Researchers typically select among these compounds based on which cytokine pathway or cell type their model targets, and study design should account for each peptide's distinct half-life and solubility profile.

Research FAQ

Frequently asked questions

What are peptides for arthritis in the context of laboratory research?

Peptides for arthritis are synthetic research compounds studied for their effects on synovial inflammation, cytokine signaling, and cartilage-preservation pathways implicated in arthritic joint disease. This collection features four mechanistically distinct compounds: BPC-157, TB-500, KPV, and ARA-290. All are intended exclusively for in vitro and in vivo laboratory research and are not supplied for human or animal therapeutic use.

How does this collection differ from peptides studied for structural joint tissue regeneration?

This collection focuses on inflammatory disease processes, such as synovial cytokine release and cartilage-preservation signaling, rather than structural connective tissue regeneration. Peptides here are studied for their interaction with inflammatory mediators like NF-kB and pro-inflammatory cytokines in arthritis models. Researchers investigating tendon, ligament, or structural tissue regeneration typically look to a separate category of compounds built around that biology.

What mechanism distinguishes KPV from the other compounds in this category?

KPV is a tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone, and it has been studied for suppressing NF-kB-mediated cytokine transcription. Its small size and melanocortin-pathway origin set it apart from the larger pentadecapeptide and thymosin-derived compounds in this collection. Preclinical interest in KPV centers on its anti-inflammatory activity in cell-based models rather than structural or vascular effects.

Why is ARA-290 included in an arthritis-focused peptide collection?

ARA-290 is included because it has been studied for cytoprotective and anti-inflammatory signaling through the innate repair receptor, a pathway distinct from the classical erythropoietin receptor and unrelated to red blood cell production. Researchers use it to examine tissue-protective signaling in models of inflammatory joint disease. Its non-hematopoietic profile makes it a useful comparator against cytokine-targeted compounds like KPV.

How do researchers decide between BPC-157 and TB-500 for arthritis-related models?

The choice generally depends on which cellular process the study targets: BPC-157 is more often selected for its documented effects on nitric oxide signaling and angiogenesis, while TB-500 is selected for its actin-binding activity and role in cell migration. Both have been examined in models involving inflamed connective tissue, but their molecular targets differ substantially. Study design, including the cell line or animal model used, typically guides the final selection.

What quality documentation should researchers expect when sourcing these peptides?

Researchers should expect third-party purity testing and a certificate of analysis for each compound before use in any research protocol. VivePeptides provides this documentation for BPC-157, TB-500, KPV, and ARA-290 to support reproducibility in inflammation and cytokine signaling studies. Verifying identity and purity is a standard prerequisite for designing controlled peptide research experiments.

Related Research Collections

Continue exploring

Peptides for RecoveryPeptides for InflammationHealing PeptidesPeptides for Joint Repair

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.